Advanced search
Publication Cover
Hematology Volume 28, 2023 - Issue 1
Submit an article Journal homepage
1,480
Views
2
CrossRef citations to date
0
Altmetric
Case Report

Brentuximab vedotin plus AVD followed by involved-node radiotherapy in a patient with classic Hodgkin lymphoma following gray zone lymphoma after autologous stem-cell transplantation failure

Norihiro Uedaa Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan;b Department of Hematology, Komaki City Hospital, Komaki, JapanView further author information
,
Harumi Katoa Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
,
Seiichi Katoc Department of Pathology and Molecular Diagnostics, Aichi Cancer Centre Hospital, Nagoya, Japan;d Center for Clinical Pathology, Fujita Health University hospital, Toyoake, JapanView further author information
,
Toko Saitoa Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
,
Hiroyuki Tachibanae Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, JapanView further author information
,
Masamitsu Yanadaa Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
,
Hirofumi Tajia Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, JapanView further author information
,
Takeshi Kodairae Department of Radiation Oncology, Aichi Cancer Center Hospital, Aichi, JapanView further author information
,
Waki Hosodac Department of Pathology and Molecular Diagnostics, Aichi Cancer Centre Hospital, Nagoya, JapanView further author information
&
Kazuhito Yamamotoa Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, JapanCorrespondence[email protected]
View further author information
 show all
Article: 2207946 | Received 02 Nov 2022, Accepted 25 Feb 2023, Published online: 15 May 2023

References

  • Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin's lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29(11):1411–1421.
  • Aussedat G, Traverse-Glehen A, Stamatoullas A, et al. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases. Br J Haematol. 2020;189(2):244–256.
  • Vassilakopoulos TP, Piperidou A, Hadjiharissi E, et al. Development of classic Hodgkin lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database. Leuk Res. 2021;100:106479.
  • Wilson WH, Pittaluga S, Nicolae A, et al. A prospective study of mediastinal gray-zone lymphoma. Blood. 2014;124(10):1563–1569.
  • Jacobsen ED, Sharman JP, Oki Y, et al. Brentuximab vedotin demonstrates objective responses in a phase 2 study of relapsed/refractory DLBCL with variable CD30 expression. Blood. 2015;125(9):1394–1402.
  • Oki Y, Ogura M, Kato H, et al. Phase II study of a salvage regimen using cyclophosphamide, high-dose cytarabine, dexamethasone, etoposide, and rituximab in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Cancer Sci. 2008;99(1):179–184.
  • Kagami Y, Yamamoto K, Shibata T, et al. R-CHOP-14 versus R-CHOP-14/CHASER for upfront autologous transplantation in diffuse large B-cell lymphoma: JCOG0908 study. Cancer Sci. 2020;111(10):3770–3779.
  • Evens AM, Kanakry JA, Sehn LH, et al. Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort. Am J Hematol. 2015;90(9):778–783.
  • Li J, Sim J, Leung AYH, et al. Favorable response of relapsed/refractory gray-zone lymphoma to brentuximab vedotin. Ann Hematol. 2018;97(3):551–554.
  • Ebisawa K, Masamoto Y, Koya J, et al. Long-term remission by brentuximab vedotin for non-mediastinal gray zone lymphoma refractory to autologous stem cell transplantation. Clin Lymphoma Myeloma Leuk. 2019;19(11):e602–e604.
  • Sarkozy C, Hung SS, Chavez EA, et al. Mutational landscape of gray zone lymphoma. Blood. 2021;137(13):1765–1776.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.